Amyloid β protein (Aβ) in Alzheimer's disease brain: Biochemical and immunocytochemical analysis with antibodies specific for forms ending at Aβ40 or Aβ42(43)

Stephen A. Gravina, Libin Ho, Christopher B. Eckman, Kristin E. Long, Laszlo Otvos, Linda H. Younkin, Nobuhiro Suzuki, Steven G Younkin

Research output: Contribution to journalArticle

510 Citations (Scopus)

Abstract

Biochemical and immunocytochemical analyses were performed to evaluate the composition of the amyloid β protein (Aβ) deposited in the brains of patients with Alzheimer's disease (AD). To quantitate all Aβs present, cerebral cortex was homogenized in 70% formic acid, and the supernatant was analyzed by sandwich enzyme-linked immunoabsorbent assays specific for various forms of Aβ. In 9 of 27 AD brains examined, there was minimal congophilic angiopathy and virtually all Aβ (96%) ended at Aβ42(43). The other 18 AD brains contained increasing amounts of Aβ ending at Aβ40. From this set, 6 brains with substantial congophilic angiopathy were separately analyzed. In these brains, the amount of Aβ ending at Aβ42(43) was much the same as in brains with minimal congophilic angiopathy, but a large amount of Aβ ending at Aβ40 (76% of total Aβ) was also present. Immunocytochemical analysis with monoclonal antibodies selective for Aβs ending at Aβ42(43) or Aβ40 confirmed that, in brains with minimal congophilic angiopathy, virtually all Aβ is Aβ ending at Aβ42(43) and showed that this Aβ is deposited in senile plaques of all types. In the remaining AD brains, Aβ42(43) was deposited in a similar fashion in plaques, but, in addition, widely varying amounts of Aβ ending at Aβ40 were deposited, primarily in blood vessel walls, where some Aβ ending at Aβ42(43) was also present. These observations indicate that Aβs ending at Aβ42(43), which are a minor component of the Aβ in human cerebrospinal fluid and plasma, are critically important in AD where they deposit selectively in plaques of all kinds.

Original languageEnglish (US)
Pages (from-to)7013-7016
Number of pages4
JournalJournal of Biological Chemistry
Volume270
Issue number13
StatePublished - Mar 31 1995
Externally publishedYes

Fingerprint

Serum Amyloid A Protein
Brain
Alzheimer Disease
Cerebral Amyloid Angiopathy
Antibodies
formic acid
Cerebrospinal fluid
Amyloid Plaques
Blood vessels
Cerebral Cortex
Blood Vessels
Cerebrospinal Fluid
Assays
Deposits
Monoclonal Antibodies
Plasmas
Enzymes

ASJC Scopus subject areas

  • Biochemistry

Cite this

Amyloid β protein (Aβ) in Alzheimer's disease brain : Biochemical and immunocytochemical analysis with antibodies specific for forms ending at Aβ40 or Aβ42(43). / Gravina, Stephen A.; Ho, Libin; Eckman, Christopher B.; Long, Kristin E.; Otvos, Laszlo; Younkin, Linda H.; Suzuki, Nobuhiro; Younkin, Steven G.

In: Journal of Biological Chemistry, Vol. 270, No. 13, 31.03.1995, p. 7013-7016.

Research output: Contribution to journalArticle

Gravina, Stephen A. ; Ho, Libin ; Eckman, Christopher B. ; Long, Kristin E. ; Otvos, Laszlo ; Younkin, Linda H. ; Suzuki, Nobuhiro ; Younkin, Steven G. / Amyloid β protein (Aβ) in Alzheimer's disease brain : Biochemical and immunocytochemical analysis with antibodies specific for forms ending at Aβ40 or Aβ42(43). In: Journal of Biological Chemistry. 1995 ; Vol. 270, No. 13. pp. 7013-7016.
@article{cb5871aa25a34e44bfd0c2c32f8aa773,
title = "Amyloid β protein (Aβ) in Alzheimer's disease brain: Biochemical and immunocytochemical analysis with antibodies specific for forms ending at Aβ40 or Aβ42(43)",
abstract = "Biochemical and immunocytochemical analyses were performed to evaluate the composition of the amyloid β protein (Aβ) deposited in the brains of patients with Alzheimer's disease (AD). To quantitate all Aβs present, cerebral cortex was homogenized in 70{\%} formic acid, and the supernatant was analyzed by sandwich enzyme-linked immunoabsorbent assays specific for various forms of Aβ. In 9 of 27 AD brains examined, there was minimal congophilic angiopathy and virtually all Aβ (96{\%}) ended at Aβ42(43). The other 18 AD brains contained increasing amounts of Aβ ending at Aβ40. From this set, 6 brains with substantial congophilic angiopathy were separately analyzed. In these brains, the amount of Aβ ending at Aβ42(43) was much the same as in brains with minimal congophilic angiopathy, but a large amount of Aβ ending at Aβ40 (76{\%} of total Aβ) was also present. Immunocytochemical analysis with monoclonal antibodies selective for Aβs ending at Aβ42(43) or Aβ40 confirmed that, in brains with minimal congophilic angiopathy, virtually all Aβ is Aβ ending at Aβ42(43) and showed that this Aβ is deposited in senile plaques of all types. In the remaining AD brains, Aβ42(43) was deposited in a similar fashion in plaques, but, in addition, widely varying amounts of Aβ ending at Aβ40 were deposited, primarily in blood vessel walls, where some Aβ ending at Aβ42(43) was also present. These observations indicate that Aβs ending at Aβ42(43), which are a minor component of the Aβ in human cerebrospinal fluid and plasma, are critically important in AD where they deposit selectively in plaques of all kinds.",
author = "Gravina, {Stephen A.} and Libin Ho and Eckman, {Christopher B.} and Long, {Kristin E.} and Laszlo Otvos and Younkin, {Linda H.} and Nobuhiro Suzuki and Younkin, {Steven G}",
year = "1995",
month = "3",
day = "31",
language = "English (US)",
volume = "270",
pages = "7013--7016",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "13",

}

TY - JOUR

T1 - Amyloid β protein (Aβ) in Alzheimer's disease brain

T2 - Biochemical and immunocytochemical analysis with antibodies specific for forms ending at Aβ40 or Aβ42(43)

AU - Gravina, Stephen A.

AU - Ho, Libin

AU - Eckman, Christopher B.

AU - Long, Kristin E.

AU - Otvos, Laszlo

AU - Younkin, Linda H.

AU - Suzuki, Nobuhiro

AU - Younkin, Steven G

PY - 1995/3/31

Y1 - 1995/3/31

N2 - Biochemical and immunocytochemical analyses were performed to evaluate the composition of the amyloid β protein (Aβ) deposited in the brains of patients with Alzheimer's disease (AD). To quantitate all Aβs present, cerebral cortex was homogenized in 70% formic acid, and the supernatant was analyzed by sandwich enzyme-linked immunoabsorbent assays specific for various forms of Aβ. In 9 of 27 AD brains examined, there was minimal congophilic angiopathy and virtually all Aβ (96%) ended at Aβ42(43). The other 18 AD brains contained increasing amounts of Aβ ending at Aβ40. From this set, 6 brains with substantial congophilic angiopathy were separately analyzed. In these brains, the amount of Aβ ending at Aβ42(43) was much the same as in brains with minimal congophilic angiopathy, but a large amount of Aβ ending at Aβ40 (76% of total Aβ) was also present. Immunocytochemical analysis with monoclonal antibodies selective for Aβs ending at Aβ42(43) or Aβ40 confirmed that, in brains with minimal congophilic angiopathy, virtually all Aβ is Aβ ending at Aβ42(43) and showed that this Aβ is deposited in senile plaques of all types. In the remaining AD brains, Aβ42(43) was deposited in a similar fashion in plaques, but, in addition, widely varying amounts of Aβ ending at Aβ40 were deposited, primarily in blood vessel walls, where some Aβ ending at Aβ42(43) was also present. These observations indicate that Aβs ending at Aβ42(43), which are a minor component of the Aβ in human cerebrospinal fluid and plasma, are critically important in AD where they deposit selectively in plaques of all kinds.

AB - Biochemical and immunocytochemical analyses were performed to evaluate the composition of the amyloid β protein (Aβ) deposited in the brains of patients with Alzheimer's disease (AD). To quantitate all Aβs present, cerebral cortex was homogenized in 70% formic acid, and the supernatant was analyzed by sandwich enzyme-linked immunoabsorbent assays specific for various forms of Aβ. In 9 of 27 AD brains examined, there was minimal congophilic angiopathy and virtually all Aβ (96%) ended at Aβ42(43). The other 18 AD brains contained increasing amounts of Aβ ending at Aβ40. From this set, 6 brains with substantial congophilic angiopathy were separately analyzed. In these brains, the amount of Aβ ending at Aβ42(43) was much the same as in brains with minimal congophilic angiopathy, but a large amount of Aβ ending at Aβ40 (76% of total Aβ) was also present. Immunocytochemical analysis with monoclonal antibodies selective for Aβs ending at Aβ42(43) or Aβ40 confirmed that, in brains with minimal congophilic angiopathy, virtually all Aβ is Aβ ending at Aβ42(43) and showed that this Aβ is deposited in senile plaques of all types. In the remaining AD brains, Aβ42(43) was deposited in a similar fashion in plaques, but, in addition, widely varying amounts of Aβ ending at Aβ40 were deposited, primarily in blood vessel walls, where some Aβ ending at Aβ42(43) was also present. These observations indicate that Aβs ending at Aβ42(43), which are a minor component of the Aβ in human cerebrospinal fluid and plasma, are critically important in AD where they deposit selectively in plaques of all kinds.

UR - http://www.scopus.com/inward/record.url?scp=0028915895&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028915895&partnerID=8YFLogxK

M3 - Article

C2 - 7706234

AN - SCOPUS:0028915895

VL - 270

SP - 7013

EP - 7016

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 13

ER -